Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Alterity, Chemomab, Yoltech.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Asceltis, Astrazeneca.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Eyestem, Entera, Telix.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ena, Opthea, Senhwa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ena, Opthea, Senhwa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Genelux, Merck, Opthea, Ractigen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Innovent, Taimed.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Innocare, Shionogi.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biocon, Clarity, Daiichi, Opthea, Protagonist.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biocity, Cstone, Delta-Fly, Innocare, Yoltech.